PharmAthene, Inc. (NYSE:PIP) was the target of a large decrease in short interest in September. As of September 30th, there was short interest totalling 1,824,728 shares, a decrease of 3.4% from the September 15th total of 1,888,701 shares. Based on an average daily trading volume, of 270,493 shares, the days-to-cover ratio is presently 6.7 days. Approximately 2.9% of the shares of the company are short sold.

Separately, TheStreet raised PharmAthene from a “sell” rating to a “hold” rating in a research note on Wednesday, August 10th.

PharmAthene (NYSE:PIP) opened at 2.80 on Wednesday. PharmAthene has a 52 week low of $1.38 and a 52 week high of $2.92. The firm’s 50-day moving average price is $2.74 and its 200-day moving average price is $2.45. The company has a market capitalization of $183.65 million and a price-to-earnings ratio of 45.16.

About PharmAthene

Pharmathene, Inc (Pharmathene) is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company’s anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes.

5 Day Chart for NYSE:PIP

Receive News & Stock Ratings for PharmAthene Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmAthene Inc. and related stocks with our FREE daily email newsletter.